Advertisement

Topics

MHRA and EMA divorce process continues ahead of Brexit deadline

10:29 EDT 4 Sep 2018 | BioPharma-Reporter

It has been revealed that the EMA is awarding significantly fewer contracts to evaluate the application of new drugs to the MHRA, as the Brexit deadline nears.

Original Article: MHRA and EMA divorce process continues ahead of Brexit deadline

NEXT ARTICLE

More From BioPortfolio on "MHRA and EMA divorce process continues ahead of Brexit deadline"

Advertisement
Quick Search
Advertisement
Advertisement